Chongqing Lummy Pharmaceutical Cash Flow Reinvestment Rate
Chongqing Lummy Pharmaceutical cash flow reinvestment rate. Chongqing Lummy Pharmaceutical (300006) has a Cash Flow Reinvestment Rate of 0.79x as of June 2025, reinvesting CN¥32.60 Million (capex CN¥7.00 Million plus investments CN¥25.60 Million) from operating cash flow of CN¥41.27 Million. Explore how well can Chongqing Lummy Pharmaceutical service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Chongqing Lummy Pharmaceutical (2006–2024)
Cash flow reinvestment rate of Chongqing Lummy Pharmaceutical from 2006 to 2024. Historical reinvestment intensity for Chongqing Lummy Pharmaceutical across 17 annual periods. Explore Chongqing Lummy Pharmaceutical (300006) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Chongqing Lummy Pharmaceutical Cash Flow Reinvestment Rate by Year (2006–2024)
Chongqing Lummy Pharmaceutical cash flow reinvestment rate by year from 2006 to 2024. Year-by-year capital reinvestment analysis for Chongqing Lummy Pharmaceutical. For the full cash flow conversion analysis, see 300006 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.43x | CN¥79.71 Million | CN¥185.03 Million | CN¥75.51 Million | ▼ -81.2% |
| 2023 | 2.29x | CN¥186.43 Million | CN¥81.53 Million | CN¥59.32 Million | ▼ -12.0% |
| 2022 | 2.60x | CN¥148.38 Million | CN¥57.13 Million | CN¥68.18 Million | ▲ +83.9% |
| 2021 | 1.41x | CN¥152.95 Million | CN¥108.28 Million | CN¥38.66 Million | ▲ +171.0% |
| 2020 | 0.52x | CN¥117.04 Million | CN¥224.54 Million | CN¥43.58 Million | ▲ +12.2% |
| 2019 | 0.46x | CN¥107.47 Million | CN¥231.30 Million | CN¥63.07 Million | ▼ -73.9% |
| 2018 | 1.78x | CN¥402.62 Million | CN¥225.89 Million | CN¥125.93 Million | ▼ -14.7% |
| 2017 | 2.09x | CN¥128.34 Million | CN¥61.39 Million | CN¥21.23 Million | ▲ +1.3% |
| 2016 | 2.06x | CN¥259.43 Million | CN¥125.66 Million | CN¥76.98 Million | ▼ -56.6% |
| 2013 | 4.76x | CN¥355.40 Million | CN¥74.70 Million | CN¥355.40 Million | ▼ -51.2% |
| 2012 | 9.75x | CN¥177.33 Million | CN¥18.18 Million | CN¥177.33 Million | ▼ -14.4% |
| 2011 | 11.40x | CN¥135.10 Million | CN¥11.85 Million | CN¥135.10 Million | ▲ +333.8% |
| 2010 | 2.63x | CN¥98.97 Million | CN¥37.66 Million | CN¥98.97 Million | ▲ +423.9% |
| 2009 | 0.50x | CN¥18.74 Million | CN¥37.35 Million | CN¥18.74 Million | ▼ -65.5% |
| 2008 | 1.46x | CN¥25.10 Million | CN¥17.25 Million | CN¥25.10 Million | ▲ +71.2% |
| 2007 | 0.85x | CN¥18.43 Million | CN¥21.68 Million | CN¥18.43 Million | ▼ -57.5% |
| 2006 | 2.00x | CN¥15.54 Million | CN¥7.77 Million | CN¥15.54 Million | — |